P. R. Perrillo, W. Teresa, R. Jorge, L. Gary, S. Eugene, G. Robert, M. Paul, D. Jules, A. Paul, D. Rolland, A. Gaya, B. Steve, C. Lynn and B. Nathaniel, “A Multicenter United States—Canadian Trial to Assess Lamivudine Monotherapy before and after Liver Transplantation for Chronic Hepatitis B,” Hepatology, Vol. 33, No. 2, 2001, pp. 424-432. doi:10.1053/jhep.2001.21554

has been cited by the following article:

• TITLE: Immune Augmentation of Injectable PLGA – Dextran (PLDEX) a Double Polymeric Microspheres as an Adjuvant for Hepatitis B Vaccine

  AUTHORS: Sivakumar Sivagurunathan Moni, Sukumaran Natarajapillai, Mohammed M. Safhi

  KEYWORDS: HBsAg; PLGA – Dextran Microspheres; Vaccine Delivery; Immunogenicity

  JOURNAL NAME: World Journal of Vaccines, Vol.1 No.3, August 24, 2011

  ABSTRACT: A new method has been developed to prepare microspheres by blending PLGA and dextran polymers (PLDEX) using solvent evaporation technique. Recombinant hepatitis B vaccine (HBsAg) was incorporated in to the double polymeric system. The objective of this study was to investigate the feasibility of PLDEX polymeric microspheres as an adjuvant for hepatitis B vaccine (HBsAg). The present study demonstrates the immunogenicity profile of HBsAg encapsulated in PLDEX and compared their efficacy with alum adsorbed HBsAg. The single intramuscular injection of HBsAg loaded PLDEX microspheres in Wistar rats resulted satisfactory antibody titers. Based on in vivo findings PLDEX microspheres were able induce satisfactory immune response.